BMC Womens Health May 2023 PMID 37161454

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.

Jonathan D C Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai, Miruna David, Mara Ozolins, Louise Jackson, Zainab Abdali, Trish M Hepburn, Frances Griffiths, Alan Montgomery, Jane Daniels, Alice Manley, Gillian Dean, Lindsay K Armstrong-Buisseret

Full text PDF Download social card

Mentions

Peak: 2 in May 2023

across 3 sources since May 2023

Extended reach

25,671

potential audience

Total likes

Video views

222

Mentions per month

May 2023 – Sep 2025

Where it's discussed

YouTube3 videos
X / Twitter2 posts
News2 articles

AI synopsis

What people are saying

The discussions indicate a neutral reception, with references to the publication and its findings, such as mentioning the comparison between lactic acid gel and metronidazole, and sharing links to research outlets. The tone remains informational, with some use of academic hashtags, reflecting moderate engagement and interest.

AgreementModerate agreement

The posts show general agreement with the study, acknowledging its contribution to understanding treatment options for bacterial vaginosis.

InterestModerate interest

There is moderate interest, as posts reference the research directly and use academic hashtags, but lack expressions of excitement or controversy.

EngagementModerate engagement

The discussions reference the publication and include mentions of the journal and trial details, indicating some engagement, though not deeply analytical.

ImpactNeutral impact

The impact appears neutral; the posts inform about the study but do not suggest immediate changes in practice or widespread influence.

Abstract in brief

The study compared the effectiveness of intravaginal lactic acid gel and oral metronidazole in treating recurrent bacterial vaginosis (BV), finding that metronidazole led to a higher rate of symptom resolution within two weeks.
Despite initial treatment success, recurrence rates within six months were similar for both treatments, with about 70-71% of women experiencing symptom recurrence regardless of the therapy.
Side effects were reported but are not detailed here; overall, the trial suggests that while metronidazole is more effective initially, both treatments have comparable long-term recurrence rates.

Read the full abstract

All mentions

Vaginal Microbiome and Women's Reproductive Health Insights

Fempower Health · Mar 12, 2024 92 views

Vaginal Microbiome and Reproductive Health Insights by Dr. Mitchell

Learn how your vaginal flora and gut microbiome contribute to your reproductive health. Dr. Caroline Mitchell discusses the importance of a healthy microbiome, bacterial vaginosis challenges, and the connection between…

Fempower Health · Jul 30, 2024 72 views

Understanding Vaginal Microbiome's Role in Women's Reproductive Health

Learn how your vaginal flora and gut microbiome contribute to your reproductive health. Dr. Caroline Mitchell shares her expertise on the importance of a healthy vaginal microbiome and its impact on women's health.

Fempower Health · Jul 30, 2024 59 views

BMC Series

@BMC_series · X

RT @ISRCTN: Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomis…

May 12, 2023 · 1 share · 21,285 followers View post →

ISRCTN: the UK's Clinical Study Registry

@ISRCTN · X

May 12, 2023 · 1 share · 4,141 followers View post →

Assessment and Treatment of Vaginitis.6 | PDF | Candidiasis | Vagina

News

doi: 10.1371/journal. Health 2023;23:241. doi: 10.1186/s12905-023-02303-5 pone.0280954 61. Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, 46. Mikamo H ...

Dec 31, 2025 View →

Period Poverty Presentation | PDF | Menstruation | Mammal Female ...